In this study, mixed-cancer panel found that ACSL4 had different degrees of genetic changes in 21 cancers, among which ACSL4 was most prone to genetic changes in Endometrial carcinoma, Melanoma and Sarcoma. Here, ACSL4 is linked to cancer.